We are live on ! Find out more
DRUG

Bright Minds Biosciences

64 hedge funds and large institutions have $366M invested in Bright Minds Biosciences in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,700% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 1

167% more capital invested

Capital invested by funds: $137M → $366M (+$229M)

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

69% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 13

36% more funds holding

Funds holding: 4764 (+17)

11.42% more ownership

Funds ownership: 74.34%85.76% (+11%)

Holders
64
Holders Change
+17
Holders Change %
+36.17%
% of All Funds
0.84%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
18
Increased
22
Reduced
13
Closed
1
Calls
Puts
Net Calls
Net Calls Change

DRUG Hedge Fund Activity: Q3 2025 in Review

64 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Bright Minds Biosciences (DRUG) for Q3 2025, worth a combined $366M — up 167% from $137M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new DRUG positions and 1 closed out — a net gain of 17 holders — while 22 added to existing stakes and 13 trimmed.

The largest buyer was Braidwell, opening a new position worth an estimated $11.8M. The largest seller was Sio Capital Management, cutting an estimated $12.5M.

  • 64 institutional investors held Bright Minds Biosciences (DRUG) as of Q3 2025, up from 47 in Q2 2025.
  • Funds reported $366M of Bright Minds Biosciences stock for Q3 2025, up 167% quarter-over-quarter.
  • 18 funds opened new Bright Minds Biosciences positions in Q3 2025 and 1 closed out, a net change of +17 holders.
  • The largest Bright Minds Biosciences buyer in Q3 2025 was Braidwell, an estimated $11.8M added.
  • The largest Bright Minds Biosciences seller in Q3 2025 was Sio Capital Management, an estimated $12.5M sold.

Based on aggregated 13F filings for Q3 2025.